^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Lyophilized formulation tested.

^d Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^e Tested in Ringer’s injection, lactated.

^f Test performed using the formulation WITHOUT edetate disodium

^g Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^h Tested undiluted.

ⁱ Quinupristin and dalfopristin components combined.

^j Tested in both dextrose 5% and sodium chloride 0.9%.

^k Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^l Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^m Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

ⁿ Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^o Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

^p Run at 100 mL/hr.

^q Tested as the premixed infusion solution.

^r Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.